Latest filing published 18 Feb 2021 for Hepion Pharmaceuticals, Inc., €17k.
Filing timeline
BuySaleInsider track record
Closed purchases
Based on 3 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Purchases by company
Since each purchase
- -56.3%Entry US$2,310.00 · Close at T+365 US$1,010.00
- -26.1%Entry US$1,650.00 · Close at T+365 US$1,220.00
- -70.5%Entry US$353,360.00 · Close at T+365 US$104,300.00
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
John T. Cavan: trading record in brief
This profile gathers the share dealings of John T. Cavan in Hepion Pharmaceuticals, Inc. The record holds 5 filings, for trades running from 20 June 2017 to 18 February 2021.
Every open-market trade on record is a purchase: 3 purchases worth €34k, and no sale. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. The rest of the record consists of 2 share grants. In 2021 alone, the filings show 1 purchase and no sales.
In size, the median ticket on the buying side is €12k. On 1 out of 3 purchases, another insider of the same company was buying within the same 30 days. When several insiders buy within a few weeks of each other, analysts speak of a cluster purchase. Looking at 3 purchases old enough to measure, the stock rose over the following 90 days in 33% of cases; the median change was -18.9%. Past outcomes like these are no guarantee of what comes next.
The latest filing, published on 18 February 2021, reports an open-market purchase of €17k in Hepion Pharmaceuticals, Inc. Typically, a trade is published a median of 2 days after it takes place. Section 16 rules allow two business days to file each Form 4. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to John T. Cavan
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 10,000 shares@ US$2.0048.3% of flowCommon StockSEC:0001104659-21-025196:0Canonical exit: 19 May 2021 (T+90)
- 4,500 shares@ US$1.62100.0% of flowCommon StockSEC:0001104659-20-130531:0Canonical exit: 23 Feb 2021 (T+90)
- 101,221 shares0Common StockSEC:0001104659-18-000925:0
- 46,726 shares0Common StockSEC:0001104659-17-044101:0
- 20,000 shares@ US$0.6565.6% of flowCommon StockSEC:0001104659-17-040822:0Canonical exit: 18 Sept 2017 (T+90)
5 of 5 declarations